| Miss Jeanne Marie Chupich, APN | |
|
1415 E State Steeet, Suite 800, Rockford, IL 61104-2333 | |
| (815) 965-2809 | |
| (815) 965-8974 |
| Full Name | Miss Jeanne Marie Chupich |
|---|---|
| Gender | Female |
| Speciality | Clinical Nurse Specialist - Women's Health |
| Location | 1415 E State Steeet, Rockford, Illinois |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922369958 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SW0102X | Clinical Nurse Specialist - Women's Health | 209004152 (Illinois) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Miss Jeanne Marie Chupich, APN 16809 Obrien Rd, Harvard, IL 60033-9536 Ph: (815) 648-4770 | Miss Jeanne Marie Chupich, APN 1415 E State Steeet, Suite 800, Rockford, IL 61104-2333 Ph: (815) 965-2809 |
News Archive
Merck & Co., Inc. announced today that the U.S. Centers for Disease Control and Prevention's (CDC's) Advisory Committee on Immunization Practices (ACIP) supports the permissive use of GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant] for boys and young men ages 9 to 26, which means that GARDASIL may be given to males ages 9 to 26 to reduce the likelihood of acquiring genital warts at the discretion of the patient's health care provider.
Surgical resection markedly improves survival among metastatic melanoma patients whose disease is isolated to a few areas in the liver, according to new study findings published in the July issue of the Journal of the American College of Surgeons.
VBL Therapeutics today announced positive results from preclinical and Phase 1 studies evaluating the company's lead anti-cancer agent, VB-111 - a first-in-class, targeted biological agent shown to work via dual-action, anti-angiogenic and vascular disruptive mechanism of action - in metastatic cancer. Preclinical data evaluating VB-111 in a comprehensive set of in vivo studies employing the Lewis Lung metastasis mouse model showed the compound to be safe and specific, with a 90% reduction in tumor burden of lung metastases after only one injection.
Fundamental research into the causes and cures of post-treatment Lyme disease syndrome now has its first home base at a major U.S. medical research center with the launch of the Johns Hopkins Lyme Disease Clinical Research Center. Inaugurated on May 12, 2015, with a major gift from the Lyme Disease Research Foundation, the center plans an ambitious research program targeting this increasingly common disease, which costs the U.S. economy up to $1.3 billion per year in treatment costs alone.
› Verified 6 days ago
Sheila Yvette Standfield, ACNS-BC Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 5666 E State St, Rockford, IL 61108 Phone: 815-226-2000 | |
Catherine A Rogers, APRN Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 1401 E State St, Rockford, IL 61104 Phone: 815-489-4891 Fax: 815-967-5312 | |
Cindy L Fearn, A.P.N. Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 324 Roxbury Rd, Rockford, IL 61107 Phone: 815-398-9491 Fax: 815-381-7498 | |
Dauphne Sims, Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 2222 E State St, Suite 209, Rockford, IL 61104 Phone: 815-988-8500 Fax: 815-977-5956 | |
April Faas, Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 5666 E State St, Rockford, IL 61108 Phone: 815-886-2000 Fax: 815-227-2370 | |
Ashley Seyfert, Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 535 Roxbury Rd, Rockford, IL 61107 Phone: 815-387-1717 Fax: 815-387-1716 | |
Catherine A Gentz, CNS Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 1401 E State St, Rockford, IL 61104 Phone: 815-961-2460 |